AEM vs MERC

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

MERC exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic ROE of -200.02%. The company is heavily over-leveraged with a Debt/Equity ratio of 23.89, suggesting an unsustainable capital structure. Despite a superficially attractive dividend yield of 16.04%, the combination of negative profit margins (-26.65%) and a technical freefall (1Y change of -78.3%) indicates a high risk of capital impairment or dividend suspension. The stock is currently trading near its 52-week low, reflecting a market that has priced in significant fundamental deterioration.